Authors: Shafiq, Sheikh; Shakeel, Faiyaz; Talegaonkar, Sushma; Ahmad, Farhan J.; Khar, Roop K.; Ali, Mushir

Source: Journal of Biomedical Nanotechnology, Volume 3, Number 1, April 2007 , pp. 28-44(17)

Publisher: American Scientific Publishers

Abstract:

Ramipril, an orally active ACE inhibitor, is poorly water soluble, highly lipophilic drug with around 28-30% of variable oral absorption. Therefore, objective of our investigation was to design a thermodynamically stable and dilutable nanoemulsion formulation of Ramipril, with minimum surfactant concentration that could improve its solubility, stability, and oral bioavailability. Pseudo ternary phase diagrams were prepared by aqueous titration method. Formulations were selected at a difference of 5% w/w ofoil from the o/w nanoemulsion region of phase diagrams, which were subjected to thermodynamic stability and dispersebility tests. The composition of optimized formulation (CF3) was Sefsol 218 (20% w/w), Cremophor-EL (13.5% w/w), Carbitol (13.5% w/w), and standard buffer solution pH 5.0 (53% w/w) as oil, surfactant, cosurfactant, and aqueous phase respectively, containing 5 mg of ramipril. The formulation showed higher drug release (99.6%), lower droplet size (34.4 nm), lower polydispersity (0.037), less viscosity (119.28 cP), and infinite dilution capability. In vitro drug release of the nanoemulsion formulations was highly significant (p < 0 01) as compared to drug suspension. The relative bioavailability of ramipril nanoemulsion when compared to conventional tablet and drug suspension was 176.3% and 428.76%, respectively. The present study revealed how nanoemulsion formulation could be optimized for the delivery of hydrophobic drug in which higher drug loading, minimum surfactant concentration, and infinite dilution can be achieved without drug precipitation that will lead to higher solubility and increased bioavailability.

References: 32 references open in new window

Articles that cite this article?

Keywords: NANOEMULSION; RAMIPRIL; BIOAVAILABILITY; SNEDDS; PHASE DIAGRAMS; SOLUBILITY; SEFSOL 218

Document Type: Research article

DOI: http://dx.doi.org/10.1166/jbn.2007.008

Publication date: 2007-04-01

More about this publication?

• Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
• Editorial Board
• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Technology ,  Biochemistry
• By this author: Shafiq, Sheikh ;  Shakeel, Faiyaz ;  Talegaonkar, Sushma ;  Ahmad, Farhan J. ;  Khar, Roop K. ;  Ali, Mushir

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers